EnWave (ENW) Planet MicroCap Showcase: VEGAS 2025 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase: VEGAS 2025 summary
3 Feb, 2026Technology and business model
Commercializes patented vacuum microwave dehydration technology for food, cannabis, and biopharma sectors, with 18 patent families protecting global IP.
Generates revenue through machine sales, ongoing royalties (2–5% of gross revenue or weight-based), and co-manufacturing services.
Focuses on building a diversified royalty portfolio, with over 50 licensed partners and machines deployed in 24 countries.
Technology offers faster, more flexible, and energy-efficient drying compared to freeze and air drying, with significant operational and environmental benefits.
Maintains a robust sales pipeline, with no current plans to raise capital due to a healthy balance sheet and credit facility.
Market traction and growth
Repeat orders and new clients are driving a snowball effect in adoption, especially among blue-chip food companies.
Royalty revenue is accelerating, with fiscal 2025 forecasted at CAD 3 million and a target to reach CAD 4.5 million to cover operating expenses.
22 large-scale machines currently deployed; goal is to reach 40 to surpass expense coverage, with manufacturing capacity for 10 per year.
Recent wins include a fourth large-scale machine sale to MicroDried and new deployments in Peru, Japan, and Brazil.
Royalty agreements last until the expiration of the last patent, currently extending to 2043, with ongoing innovation to extend IP protection.
Competitive advantages and operational highlights
Only provider of commercial-scale vacuum microwave technology globally, with proven reliability and scalability since 2013.
Machines have a smaller footprint and lower energy consumption than freeze dryers, with flexible throughput and product applications.
Co-manufacturing facility in Vancouver serves as a showroom and risk-reduction tool for potential clients.
Sales and marketing investments have expanded the team and global reach, supporting smoother, more consistent earnings.
Remote monitoring and auditing ensure accurate royalty payments and support for partners' product development.
Latest events from EnWave
- REV™ technology drives recurring royalties and global growth in food, pharma, and cannabis markets.ENW
Corporate presentation5 Mar 2026 - Revenue up 36% to CAD 1.6M, gross margin at 37%, and new license deals drive growth.ENW
Q1 202620 Feb 2026 - Doubling machine sales in 2025 could drive significant EBITDA and royalty growth.ENW
Planet MicroCap Showcase3 Feb 2026 - Accelerating royalty growth and global expansion position the business for positive EBITDA in 2026.ENW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Q2 2025 revenue surged 456%, gross margin hit 33%, and EBITDA turned positive.ENW
Q2 202527 Jan 2026 - Record royalties, margin rebound, and positive EBITDA highlight strong growth momentum.ENW
Q3 202423 Jan 2026 - Q4 2024 delivered strong revenue and net income growth, with a positive outlook for 2025.ENW
Q4 202411 Jan 2026 - Higher royalties and margins offset lower sales; losses narrowed and new deals signed.ENW
Q1 202526 Dec 2025 - Record revenue and profitability in FY2025 set the stage for continued growth in 2026.ENW
Q4 202515 Dec 2025